ABCG2 transporter reduces protein aggregation in cigarette smoke condensate-exposed A549 lung cancer cells

PLoS One. 2024 Mar 5;19(3):e0297661. doi: 10.1371/journal.pone.0297661. eCollection 2024.

Abstract

Cigarette smoke-induced protein aggregation damages the lung cells in emphysema and COPD; however, lung cancer cells continue to thrive, evolving to persist in the toxic environment. Here, we showed that upon the cigarette smoke condensate exposure, A549 lung cancer cells exhibit better survival and reduced level of protein aggregation when compared to non-cancerous Beas-2B and H-6053 cells. Our data suggests that upregulation of efflux pumps in cancer cells assists in reducing smoke toxicity. Specifically, we demonstrated that inhibition of the ABCG2 transporter in A549 by febuxostat or its downregulation by shRNA-mediated RNA interference resulted in a significant increase in protein aggregation due to smoke exposure.

MeSH terms

  • A549 Cells
  • ATP Binding Cassette Transporter, Subfamily G, Member 2* / metabolism
  • Cigarette Smoking*
  • Humans
  • Lung Neoplasms*
  • Protein Aggregates*

Substances

  • ABCG2 protein, human
  • ATP Binding Cassette Transporter, Subfamily G, Member 2
  • Protein Aggregates

Grants and funding

This work was supported by a Tobacco Settlement (CURE) grant to Pennsylvania State University, Summer Undergraduate Research Experience (SURE) to E. S., and Undergraduate Research funding to E. P, A. S., E. S., M. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.